Suggestions
Klaus Pugner
Global Market Access Executive with a track record in HTA, Pricing, HEOR, Real World Evidence, Modeling
Klaus Pugner is a seasoned professional with over 20 years of experience in the field of health economics and market access within the global biopharmaceutical industry.
Throughout his career, Klaus has been instrumental in various key achievements, including the development of the first global value dossier for a top 10 brand, the establishment of global pricing strategies, and the building of high-performing teams across different regions.
He has led initiatives such as building a European HEOR function, creating international Market Access organizations, and setting up a global economic modeling center of excellence to enhance product launches and lifecycle management.
Klaus holds a PhD in Hospital Governance, an MSc in Health Policy, Planning and Financing with Distinction, and a BA in Economics and European Studies.
He has held significant roles in renowned organizations like Takeda, Amgen, and Bristol-Myers Squibb, where he served in various executive and directorial positions focusing on health economics, market access, and outcomes research.
His expertise extends to areas such as real world evidence, medical affairs, HTA, economic modeling, and novel pricing models.
